Physician profile
David Mas
NPI 1760129563
$285.36
in general payments reported to CMS, 2019-2025
11 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.33 · 2024: $110 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $49.00 | 2025 | |
| Mylan Specialty L.P. | $38.30 | 2024 | Yupelri |
| Janssen Biotech, INC. | $29.42 | 2025 | Tremfya |
| Organon LLC | $29.41 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $23.26 | 2024 | Crysvita |
| Dexcom, INC. | $22.83 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $20.60 | 2025 | Arexvy, Shingrix |
| Dynavax Technologies Corporation | $20.34 | 2025 | Heplisav-B |
| Janssen Pharmaceuticals, INC | $19.09 | 2024 | Xarelto |
| Phadia US INC. | $18.78 | 2025 | Immunocap |
| Exact Sciences Corporation | $14.33 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.